Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Twist Bioscience Corporat...

    NASDAQ: TWST · Real-Time Price · USD
    34.66
    -1.23 (-3.43%)
    At close: Jun 20, 2025, 3:59 PM
    34.01
    -1.88%
    After-hours: Jun 20, 2025, 05:53 PM EDT
    -3.43%
    Bid 34.01
    Market Cap 2.08B
    Revenue (ttm) 347.68M
    Net Income (ttm) -191.15M
    EPS (ttm) -3.25
    PE Ratio (ttm) -10.66
    Forward PE -26.39
    Analyst Buy
    Ask 36.7
    Volume 643,646
    Avg. Volume (20D) 1,217,509
    Open 36.30
    Previous Close 35.89
    Day's Range 34.51 - 36.35
    52-Week Range 27.12 - 60.90
    Beta 2.37

    About TWST

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol TWST
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for TWST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Twist Bioscience Corporation is scheduled to release its earnings on Aug 1, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 month ago
    -8.44%
    Twist Bioscience shares are trading lower after th... Unlock content with Pro Subscription
    6 months ago
    +9.87%
    Twist Bioscience shares are trading higher after Leerink Partners maintained its Hold rating on the stock.
    news image

    4 weeks ago · businesswire.com

    Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions

    SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care se...

    news image

    1 month ago · businesswire.com

    Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today ...

    news image

    1 month ago · businesswire.com

    Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a core mid-cap growth and val...

    news image

    1 month ago · businesswire.com

    Twist Bioscience and Ginkgo Bioworks Revise Collaboration

    SOUTH SAN FRANCISCO, Calif. & BOSTON--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care secto...

    news image

    1 month ago · seekingalpha.com

    Twist Bioscience: Expansion Efforts Continue To Face Challenges

    Twist Bioscience reported solid results in Q2, but management's downbeat tone on the earnings call suggest there are challenges ahead. Twist has also spun-out its data storage business, which will hel...

    news image

    1 month ago · seekingalpha.com

    Twist Bioscience Corporation (TWST) Q2 2025 Earnings Call Transcript

    Twist Bioscience Corporation (NASDAQ:TWST ) Q2 2025 Earnings Conference Call April 5, 2025 8:00 AM ET Company Participants Angela Bitting - Senior Vice President of Corporate Affairs Emily Leproust - ...

    news image

    1 month ago · zacks.com

    Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates

    Twist Bioscience (TWST) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to loss of $0.79 per share a year ago.

    news image

    1 month ago · businesswire.com

    Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today ...

    news image

    1 month ago · businesswire.com

    Twist Bioscience Spins Out DNA Data Storage as Independent Company

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today ...

    news image

    1 month ago · seekingalpha.com

    Twist Bioscience Q2 Earnings Preview: Innovative Products, Not Enough Buyers

    Twist Bioscience has shown revenue growth from $54.4m in 2019 to potentially >$300m in 2024, but continues to post losses. Despite a diverse customer base and innovative synthetic DNA technology, Twis...

    Add to Watchlist